Blood Study of Immune Response in Leptospirosis
Part of Infections clinical trials.
This study examines how your immune system responds to leptospirosis (a bacterial infection) by analyzing blood samples. Researchers are testing a new approach to help your body fight the infection more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Suspected of having leptospirosis (a bacterial infection spread by contaminated water or animal urine)
- Able to give 40 ml of blood (about 3 tablespoons) for the study
- Enrolled in a social security or health insurance program
- Not pregnant or breastfeeding
- Not hospitalized or recovering from surgery in the past 7 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body responds to leptospirosis infection to improve diagnosis and treatment. It is for people with fever and possible leptospirosis, as well as healthy volunteers.
This study records information from people who have invasive (spreading) leptospirosis, a bacterial infection. The goal is to better understand how the disease presents and spreads, which can help improve future care.
This trial tests a structured set of hospital treatments (“care bundle”) for adults with suspected leptospirosis, a serious infection often linked to flood water exposure. It may help by improving how quickly and consistently key care steps are delivered in the hospital.
This trial tests ways to prevent early and late complications of leptospirosis, a bacterial infection. It aims to offer treatments that may reduce the risk of serious problems like kidney failure or breathing difficulties.
This study compares two antibiotic schedules (3 days vs 7 days) for adults with mild leptospirosis. It aims to find out if a shorter course works as well and is easier to tolerate.
This study looks at specific immune cells and how fats are transported in the blood to predict which people will have a severe bacterial infection (like pneumonia or sepsis). Your results may help doctors identify higher-risk patients earlier.
Hear when a new Leptospirosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.